Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Effect of BG-12 on contrast-enhanced lesions in patients with relapsing--remitting multiple sclerosis: subgroup analyses from the phase 2b study.
A dual concurrent mechanism explains trigeminal neuralgia in patients with multiple sclerosis.
Overview of the immune system.
Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions.
Fatigue and Comorbidities in Multiple Sclerosis.
Prevalence of Multiple Sclerosis in the Republic of Moldova.
Extended interval dosing of natalizumab in multiple sclerosis.
Epigenetics of Multiple Sclerosis: An Updated Review.
Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression.
Biogen Idec receives notification of PDUFA date extension
Autoimmune sleep disorders.
Kaposi sarcoma in a fingolimod-treated patient with multiple sclerosis.
Effects of Interferon β-1a and Interferon β-1b Monotherapies on Selected Serum Cytokines and Nitrite Levels in Patients with Relapsing-Remitting Multiple Sclerosis: A 3-Year Longitudinal Study.
Detection of fumarate-glutathione adducts in the portal vein blood of rats: evidence for rapid dimethylfumarate metabolism.
Alemtuzumab-Related Thyroid Dysfunction in a Phase 2 Trial of Patients with Relapsing-Remitting Multiple Sclerosis.
Sanofi Reports Positive Top-Line Results from First Phase 3 Study of Alemtuzumab (Lemtrada) in Multiple Sclerosis
In Vivo Maintenance of Human Regulatory T Cells during CD25 Blockade.
Clarity Extension Study
Therapy Optimization in Multiple Sclerosis: A cohort study of therapy adherence and risk of relapse.
Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation.
Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.
MicroRNAs: The Role in Autoimmune Inflammation.
CLIC1 regulates dendritic cell antigen processing and presentation by modulating phagosome acidification and proteolysis.
Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus.
Artesunate Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Leukocyte Migration to the Central Nervous System.

Pages